When you absolutely have to recruit patients on time.
Home Company News A Phase II Non-Small Cell Lung Cancer is starting at Accell Clinical Research
A Phase II Non-Small Cell Lung Cancer is starting at Accell Clinical Research
We have obtained regulatory approval for a Phase II study in patients with NSCLC. The clinical study will be conducted at 6 sites in Russia and will enroll 20 patients.
Company News
our SERVICES MENU
From clinical research associates to hands-on founders, we fiercely pursue our strategic goal: deliver on schedule. We think of ourselves as your development partner, not a vendor.
